Trasturel 150mg Injection
Marketer
Reliance Life Sciences
Salt Composition
Trastuzumab (150mg)
Overview Trasturel 150mg Injection
Oncaspar 150mg injection treats breast and gastric cancers by targeting and eliminating HER2-positive cancer cells. Administration is strictly via injection by a healthcare professional, with dosage and frequency determined individually by your physician based on your specific condition, potentially adjusting over time. Precise adherence to your doctor's instructions is crucial, as improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent; discontinue use only under your doctor's guidance. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can lower blood cell counts, raising infection vulnerability; regular blood tests, including monitoring of blood cell levels, cardiac function, liver health, and uric acid levels are essential. Report immediately any shortness of breath, cough, chills, or limb swelling. Inform your medical team of all other medications you are taking, as interactions are possible. This treatment is contraindicated during pregnancy or breastfeeding; reliable contraception for both partners is vital throughout the treatment period.
Primary Ingredients of Trasturel 150mg Injection
No text provided to rephrase.
Uses of Trasturel 150mg Injection
Malignancies affecting the breast and stomach.
Major Benefits of Trasturel 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Trasturel 150mg Injection:
- Anemia (low number of red blood cells)
- Chills
- Common cold
- Cough
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Fatigue
- Fever
- Headache
- Heart failure
- Infection
- Insomnia (difficulty in sleeping)
- Mucosal inflammation
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Taste change
- Upper respiratory tract infection
- Weight loss
How to use Trasturel 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Trasturel 150mg Injection works:
The injectable medication Trasturel 150mg is a monoclonal antibody (IgG1 subtype, recombinant origin). Its mechanism involves targeting HER2 receptors—proteins on breast and stomach cancer cells that drive uncontrolled cell growth. By binding to HER2, Trasturel disrupts receptor function, leading to cancer cell death. Additionally, it suppresses multiple downstream signaling cascades implicated in cancer development.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trasturel 150mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Trasturel 150mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administering Trasturel 150mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Trasturel 150mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Trasturel 150mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Trasturel 150mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Trasturel 150mg Injection :
Omitting a scheduled Trasturel 150mg injection warrants immediate physician consultation.
Facts to Know About Trasturel 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Monoclonal antibody HER2/neu (ErbB2) inhibitor |
3,018 People bought this recently